The basis of the therapy β cellular metabolism
The basis of therapy with the LuXXaMed HD2000+ microcurrent device is the modulation of cellular metabolism. SchΓΆnfelder et al. (2017) demonstrated in an in vitro study using human cell cultures that a change in cell morphology can be observed. βThis proves that the applied current β including the microcurrent from the HD2000+ β reaches the cells and is capable of influencing them.β (SchΓΆnfelder, Walker & Kenner, 2017, p. 11)
Membrane potential, protein synthesis and ATP production
In the treatment of cellular metabolism using microcurrent, there is an improvement in the cellular membrane potential, an increase in protein synthesis and ATP production. (CHENG et al., 1982, p. 3)
Furthermore, LuXXaMed GmbH has commissioned studies at the Fraunhofer Institute for Plasma and Beam Technology to gather scientific and clinical evidence regarding the HD2000+. The results of one of these studies showed: β… an increase in intracellular ATP concentration, a significant rise in metabolic activity and an increase in cell vitality…β (Karutz, 2012, II)
References
CHENG, N., van HOOF, H., BOCKX, E., HOOGMARTENS, M. J., MULIER, J. C., DIJCKER, F. J. de et al. (1982). The Effects of Electric Currents on ATP Generation, Protein Synthesis, and Membrane Transport in Rat Skin. Clinical Orthopaedics and Related Research, &NA; (171), 264β272. https://doi.org/10.1097/00003086-198211000-00045 
Karutz, A. (2012). Investigation of the influence of nanophotonics technology on in vitro cell cultures. Masterβs thesis. International University Institute Zittau, Zittau.
SchΓΆnfelder, J., Walker, S. & Kenner, L. (2017). Effect of a new generation of devices on in vitro cell cultures. AP 3: Effect of microcurrent therapy on in vitro cell cultures (Fraunhofer FEP, ed.).
https://www.luxxamed.de/2017/01/10/klinische-studie-luxxamed-hd3000/
